Series Fund - Developing Growth Portfolio
- CUSIP
- 543910855
Summary
Summary
The Fund seeks to deliver long-term growth of capital by investing primarily in stocks of small U.S. companies.
Holding | Sector | Assets |
---|
Credo Technology Group Holding Ltd | Information Technology | 2.5% |
Glaukos Corp | Health Care | 2.5% |
Reddit Inc | Communication Services | 2.4% |
CyberArk Software Ltd | Information Technology | 2.3% |
Astera Labs Inc | Information Technology | 2.3% |
Agilysys Inc | Information Technology | 2.2% |
Piper Sandler Cos | Financials | 2.0% |
FTAI Aviation Ltd | Industrials | 1.9% |
Comfort Systems USA Inc | Industrials | 1.9% |
Cava Group Inc | Consumer Discretionary | 1.9% |
Ten largest holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund’s current or future investments. The figures presented are as of the date shown, do not include the Fund’s entire investment portfolio, and may change at any given time.
Holding | Sector | Assets |
---|
FTAI Aviation Ltd | Industrials | 2.4% |
Cava Group Inc | Consumer Discretionary | 2.4% |
Piper Sandler Cos | Financials | 2.4% |
Reddit Inc | Communication Services | 2.3% |
CyberArk Software Ltd | Information Technology | 2.2% |
Comfort Systems USA Inc | Industrials | 2.2% |
Wix.com Ltd | Information Technology | 2.2% |
Glaukos Corp | Health Care | 2.2% |
Agilysys Inc | Information Technology | 2.1% |
Sweetgreen Inc | Consumer Discretionary | 2.1% |
Loar Holdings Inc | Industrials | 2.1% |
Credo Technology Group Holding Ltd | Information Technology | 2.0% |
Hamilton Lane Inc | Financials | 1.9% |
Natera Inc | Health Care | 1.9% |
Modine Manufacturing Co | Consumer Discretionary | 1.8% |
Evercore Inc | Financials | 1.8% |
MakeMyTrip Ltd | Consumer Discretionary | 1.7% |
Intra-Cellular Therapies Inc | Health Care | 1.7% |
Arcellx Inc | Health Care | 1.7% |
Guidewire Software Inc | Information Technology | 1.7% |
Q2 Holdings Inc | Information Technology | 1.7% |
Astera Labs Inc | Information Technology | 1.7% |
Vertex Inc | Information Technology | 1.6% |
Varonis Systems Inc | Information Technology | 1.6% |
Insmed Inc | Health Care | 1.6% |
Freshpet Inc | Consumer Staples | 1.4% |
Parsons Corp | Industrials | 1.4% |
Sterling Infrastructure Inc | Industrials | 1.4% |
REVOLUTION Medicines Inc | Health Care | 1.4% |
Crane Co | Industrials | 1.4% |
Itron Inc | Information Technology | 1.4% |
Moog Inc | Industrials | 1.3% |
Monday.com Ltd | Information Technology | 1.3% |
AeroVironment Inc | Industrials | 1.3% |
ADMA Biologics Inc | Health Care | 1.3% |
PROCEPT BioRobotics Corp | Health Care | 1.3% |
SpringWorks Therapeutics Inc | Health Care | 1.2% |
Impinj Inc | Information Technology | 1.1% |
Life Time Group Holdings Inc | Consumer Discretionary | 1.1% |
SPX Technologies Inc | Industrials | 1.1% |
AAON Inc | Industrials | 1.1% |
Descartes Systems Group Inc/The | Information Technology | 1.1% |
MACOM Technology Solutions Holdings Inc | Information Technology | 1.1% |
Krystal Biotech Inc | Health Care | 1.1% |
Doximity Inc | Health Care | 1.0% |
Blueprint Medicines Corp | Health Care | 1.0% |
Sprouts Farmers Market Inc | Consumer Staples | 1.0% |
Duolingo Inc | Consumer Discretionary | 1.0% |
Crinetics Pharmaceuticals Inc | Health Care | 0.9% |
Stride Inc | Consumer Discretionary | 0.9% |
Intapp Inc | Information Technology | 0.9% |
Maplebear Inc | Consumer Staples | 0.9% |
Tarsus Pharmaceuticals Inc | Health Care | 0.9% |
Primo Brands Corp | Consumer Staples | 0.9% |
Nuvalent Inc | Health Care | 0.9% |
Fabrinet | Information Technology | 0.8% |
Zeta Global Holdings Corp | Information Technology | 0.8% |
Clear Secure Inc | Information Technology | 0.8% |
Dutch Bros Inc | Consumer Discretionary | 0.8% |
Mirion Technologies Inc | Information Technology | 0.8% |
Kratos Defense & Security Solutions Inc | Industrials | 0.8% |
GeneDx Holdings Corp | Health Care | 0.8% |
Core Scientific Inc | Information Technology | 0.8% |
RxSight Inc | Health Care | 0.8% |
Merus NV | Health Care | 0.8% |
Clearwater Analytics Holdings Inc | Information Technology | 0.7% |
Shake Shack Inc | Consumer Discretionary | 0.7% |
Ollie's Bargain Outlet Holdings Inc | Consumer Discretionary | 0.7% |
Vaxcyte Inc | Health Care | 0.7% |
Avidity Biosciences Inc | Health Care | 0.7% |
Primoris Services Corp | Industrials | 0.6% |
Vital Farms Inc | Consumer Staples | 0.6% |
Janux Therapeutics Inc | Health Care | 0.6% |
Mirum Pharmaceuticals Inc | Health Care | 0.6% |
Vera Therapeutics Inc | Health Care | 0.5% |
Madrigal Pharmaceuticals Inc | Health Care | 0.5% |
Klaviyo Inc | Information Technology | 0.5% |
Universal Technical Institute Inc | Consumer Discretionary | 0.3% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Fund Documents
Fund Documents
Portfolio Holdings 1Q
Publish Date:11/03/2015
|
||||
Portfolio Holdings 3Q
Publish Date:11/03/2015
|
||||
Summary Prospectus
Publish Date:11/03/2015
|
||||
Statutory Prospectus
Publish Date:11/03/2015
|
||||
SAI
Publish Date:11/03/2015
|
||||
Annual Financial Statements and Other Information *
Publish Date:11/03/2015
|
||||
Semi-Annual Tailored Shareholder Report
Publish Date:11/03/2015
|
||||
Semi-Annual Financial Statements and Other Information *
Publish Date:11/03/2015
|
||||
Fact Sheet
Publish Date:11/03/2015
|
Other Important Information
Portfolio shares of the Lord Abbett Series Funds are not offered directly to the public. These shares are currently offered only to separate accounts of certain insurance companies that are unaffiliated with Lord Abbett.
The Fund's portfolio is actively managed and is subject to change. Holdings are for informational purposes only and are not a recommendation to buy, sell, or hold any security.
The investment return and principal value of an investment in the Fund will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than their original cost. To obtain performance data current to the most recent quarter-end, go to quarter ending performance on our Website or call Lord Abbett at (888) 522-2388.
Investors should carefully consider the investment objectives, risks charges and expenses of the Lord Abbett Funds. This and other important information is contained in the fund's summary prospectus and/or prospectus. To obtain a prospectus or summary prospectus on any Lord Abbett mutual fund, you can click here, contact your investment professional or Lord Abbett Distributor LLC at (888) 522-2388. Read the prospectus carefully before you invest or send money.